REQUEST A DEMO
Total
USD $0.00
Search more companies

Daewoong Pharmaceutical (India) Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Daewoong Pharmaceutical (India) Private Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Daewoong Pharmaceutical (india) Private Limited is an unlisted company, incorporated on 30/11/2012. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U24232TG2012FTC084511 and registration number is 084511. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
Plot No.5A, A.P.I.I.C Kukatpally
Hyderabad; Telangana; Postal Code: 500072

Contact Details: Purchase the Daewoong Pharmaceutical (India) Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Daewoong Pharmaceutical (India) Private Limited report to view the information.
Registered Capital:
Purchase the Daewoong Pharmaceutical (India) Private Limited report to view the information.
Incorporation Date:
November 30, 2012
Key Executives
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Daewoong Pharmaceutical (India) Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
2.85%
Total operating revenue
3.07%
Operating profit (EBIT)
-4.2%
EBITDA
11.22%
Net Profit (Loss) for the Period
-22.52%
Total assets
159.39%
Total equity
10.49%
Operating Profit Margin (ROS)
-0.93%
Net Profit Margin
-2.72%
Return on Equity (ROE)
-4.04%
Quick Ratio
-7.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?